Cognetivity Neurosciences LtdCanadian Securities Exchange:CGNView on OTC Pink - Current Information
- LAST PRICE0.0200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.0150/ 1,327
- Ask / Lots0.0250/ 97
- Open / Previous Close0.0200 / 0.0200
- Day Range
- 52 Week Range
- Volume30,000
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CGN |
|---|---|---|
| 01:53 ET | 30000 | 0.02 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Cognetivity Neurosciences Ltd | 1.8M | -0.2x | --- |
Binovi Technologies Corp | 2.3M | 0.0x | --- |
Pangenomic Health Inc | 839.7K | -0.1x | --- |
TruTrace Technologies Inc | 763.5K | -0.4x | --- |
FluroTech Ltd | 605.2K | -5.7x | --- |
Therma Bright Inc | 3.2M | -0.9x | --- |
Company Information
Cognetivity Neurosciences Ltd. is a Canada-based technology company. The Company has developed a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial and consumer environments for potentially allowing early diagnosis of dementia. The Company’s ICA uses artificial intelligence and machine learning techniques to detect the earliest signs of cognitive impairment by testing the performance of brain. Its products include CognICA and OptiMind. The CognICA has various applications from providing a measure of cognitive function, to long-term health monitoring, corporate wellness, and personalized brain health. The OptiMind is a wellness app that measures individuals everyday cognitive performance. The Company serves various industries, including healthcare, elder care, enterprise, everyday use, and research. The ICA is available for clinical use in the United States of America, United Kingdom and Europe.
Contact Information
- Headquarters
- Suite 1430, 800 West Pender St.VANCOUVER, BC, Canada V6C 2V6
- Phone
- 604-363-0411
- Fax
- 604-688-9588
Executives
- Chief Executive Officer, Director
- Sina Habibi
- Chief Financial Officer, Chief Operating Officer, Corporate Secretary, Director
- Thomas Sawyer
- Chief Scientific Officer
- Seyed Madhi Khaligh Razavi
- Chief Medical Officer, Director
- Christos Kalafatis
- Director
- Desmond Balakrishnan
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.8M |
|---|---|
Revenue (TTM) | $99.0K |
Shares Outstanding | 88.6M |
Cognetivity Neurosciences Ltd does not pay a dividend. | |
Beta | -0.38 |
EPS | $-0.08 |
Book Value | $-0.12 |
P/E Ratio | -0.2x |
Price/Sales (TTM) | 17.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -4,192.15% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
